VEGFA and endophthalmitis: This case study presents a newborn who faced two challenges: 1‐bilateral APROP due to his very early birth at 30 weeks which needed an intravitreal anti‐VEGF injection, 2‐Nasolacrimal duct obstruction and purulent discharge that increases the risk of endophthalmitis.